Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Nadal

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Molecular Cancer|February 20, 2018
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old targetMarta Román, Iosune Baraibar, Inés López, et al.
Clinical Lung Cancer|December 6, 2021
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR MutationsHidetoshi Hayashi, Ernest Nadal, Jhanelle E Gray, et al.
Future Oncology (London, England)|June 3, 2025
Matching-adjusted indirect comparison of selpercatinib and pralsetinib in <i>RET</i> fusion-positive non-small cell lung cancerMaximilian Hochmair, Urpo Kiiskinen, Yulia D'yachkova, et al.
ESMO Open|November 16, 2016
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapyChiara Ambrogio, Ernest Nadal, Alberto Villanueva, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2024
Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidenceErnest Nadal, Nada Rifi, Sarah Kane, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 22, 2015
The role of Dickkopf-3 overexpression in esophageal adenocarcinomaZhuwen Wang, Lin Lin, Dafydd G Thomas, et al.
Enfermeria Clinica|February 14, 2026
Educational intervention in advanced practice nursing for managing symptoms, toxicities, and quality of life in patients with lung cancerIsabel Brao-Pérez, Mónica Arellano-Vengoechea, Francesc Torrent-Llagostera, et al.
Cell Death & Disease|April 10, 2026
Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolyticsIswarya Sreeram, Sílvia Plans-Marin, Mabel Cruz-Rodríguez, et al.
Disease Models & Mechanisms|February 2, 2022
Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegansCarmen Martínez-Fernández, Milana Bergamino, Alfonso Schiavi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2026
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerabilityGerrina Ruiter, Xiuning Le, Ross A Soo, et al.
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Molecular Cancer|February 20, 2018
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old targetMarta Román, Iosune Baraibar, Inés López, et al.
Clinical Lung Cancer|December 6, 2021
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR MutationsHidetoshi Hayashi, Ernest Nadal, Jhanelle E Gray, et al.
Future Oncology (London, England)|June 3, 2025
Matching-adjusted indirect comparison of selpercatinib and pralsetinib in <i>RET</i> fusion-positive non-small cell lung cancerMaximilian Hochmair, Urpo Kiiskinen, Yulia D'yachkova, et al.
ESMO Open|November 16, 2016
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapyChiara Ambrogio, Ernest Nadal, Alberto Villanueva, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2024
Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidenceErnest Nadal, Nada Rifi, Sarah Kane, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 22, 2015
The role of Dickkopf-3 overexpression in esophageal adenocarcinomaZhuwen Wang, Lin Lin, Dafydd G Thomas, et al.
Enfermeria Clinica|February 14, 2026
Educational intervention in advanced practice nursing for managing symptoms, toxicities, and quality of life in patients with lung cancerIsabel Brao-Pérez, Mónica Arellano-Vengoechea, Francesc Torrent-Llagostera, et al.
Cell Death & Disease|April 10, 2026
Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolyticsIswarya Sreeram, Sílvia Plans-Marin, Mabel Cruz-Rodríguez, et al.
Disease Models & Mechanisms|February 2, 2022
Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegansCarmen Martínez-Fernández, Milana Bergamino, Alfonso Schiavi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2026
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerabilityGerrina Ruiter, Xiuning Le, Ross A Soo, et al.
Pageof 17